| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_999d226f47b8b0eca8727782676047f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fcc3d503d2d45dfbb25dfdd77a184e0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0682 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-22 |
| filingDate |
1997-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_792064910cd7b6d65fc79a965c8eae15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12acc7a8ddf535af7774eebc477f4e09 |
| publicationDate |
1999-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100225491-B1 |
| titleOfInvention |
Human cervical cancer cell line |
| abstract |
The present invention relates to a human cervical cancer cell line. Specifically, the mutant human papillomavirus-16 type, in which the 29th amino acid of the E7 protein is substituted with asparagine and serine, is inserted with more than 600 copies per cell and episomal state. The present invention relates to the human cervical cancer cell line SNU-1000. |
| priorityDate |
1997-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |